news
05-20-2021, 05:46 AM
The government has so far paid Emergent BioSolutions $271 million, even though American regulators have yet to clear a single dose of vaccine produced at its manufacturing plant in Baltimore.
More... (https://www.nytimes.com/2021/05/19/us/politics/emergent-biosolutions-vaccine-bonuses.html)
More... (https://www.nytimes.com/2021/05/19/us/politics/emergent-biosolutions-vaccine-bonuses.html)